id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-4561-0004,FDA,FDA-2015-D-4561,"Head Lice Infestation: Developing Drugs for Topical Treatment; Guidance
for Industry; Availability",Notice,Notice of Availability,2016-10-06T04:00:00Z,2016,10,2016-10-06T04:00:00Z,,2016-10-06T16:19:20Z,2016-24233,0,0,090000648229eef0
FDA-2015-D-4561-0005,FDA,FDA-2015-D-4561,Head Lice Infestation: Developing Drugs for Topical Treatment Guidance for Industry,Other,Guidance,2016-10-06T04:00:00Z,2016,10,2016-10-06T04:00:00Z,,2024-11-12T06:14:40Z,,1,0,09000064822a1138
FDA-2015-D-4561-0001,FDA,FDA-2015-D-4561,"Head Lice Infestation: Developing Drugs for Topical Treatment; Draft
Guidance for Industry; Availability",Notice,Notice of Availability,2015-12-15T05:00:00Z,2015,12,2015-12-15T05:00:00Z,2016-03-15T03:59:59Z,2016-03-16T20:00:25Z,2015-31406,0,0,0900006481da7377
FDA-2015-D-4561-0002,FDA,FDA-2015-D-4561,"Head Lice Infestation: Developing Drugs for Topical Treatment
Guidance for Industry",Other,Guidance,2015-12-15T05:00:00Z,2015,12,2015-12-15T05:00:00Z,,2019-10-21T16:14:14Z,,0,0,0900006481da806f